PF-Succinylcholine Chloride (Nephron) – Incorrect Labeling (2019)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.
Brand
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Lot Codes / Batch Numbers
Lots: SU9079A, SU9079B, Exp 4/5/2020
Products Sold
Lots: SU9079A, SU9079B, Exp 4/5/2020
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center is recalling PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, due to Incorrect labeling: Incorrect or missing lot and/or exp date. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Incorrect labeling: Incorrect or missing lot and/or exp date
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026